Clinical Trial Update: First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641 [Phase 1]

View source ↗

Summary

First-in-human Phase 1 trial in healthy adults to evaluate safety, tolerability, and pharmacokinetics of LPX-TI641; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• Multiple Sclerosis

Drugs mentioned

• LPX-TI641

Snippet

Sponsor: LAPIX Therapeutics Inc. | Conditions: Autoimmune Diseases, Multiple Sclerosis | Phase 1 | Status: COMPLETED